We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
- Authors
Najjar, Samer S; Rao, Sunil V; Melloni, Chiara; Raman, Subha V; Povsic, Thomas J; Melton, Laura; Barsness, Gregory W; Prather, Kristi; Heitner, John F; Kilaru, Rakhi; Gruberg, Luis; Hasselblad, Vic; Greenbaum, Adam B; Patel, Manesh; Kim, Raymond J; Talan, Mark; Ferrucci, Luigi; Longo, Dan L; Lakatta, Edward G; Harrington, Robert A; REVEAL Investigators
- Abstract
Acute ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality. In experimental models of MI, erythropoietin reduces infarct size and improves left ventricular (LV) function.
- Publication
JAMA, 2011, Vol 305, Issue 18, p1863
- ISSN
1538-3598
- Publication type
Journal Article
- DOI
10.1001/jama.2011.592